Physician profile
Sherwin Benlevi
NPI 1558675686
$1,268.42
in general payments reported to CMS, 2019-2025
11 companies · $296 in 2025
The $296 reported for 2025 was more than what 83% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $87.28 · 2021: $114 · 2022: $72.26 · 2023: $183 · 2024: $250 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $461.84 | 2019-2025 | Arestin |
| Corcept Therapeutics | $202.57 | 2025 | Korlym |
| Align Technology, INC. | $179.30 | 2021-2025 | Invisalign |
| Teva Pharmaceuticals USA, INC. | $135.00 | 2023 | Austedo |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Dentsply Sirona INC | $54.34 | 2019-2020 | |
| Dentsply Sirona Orthodontics INC | $38.71 | 2019 | |
| Peter Brasseler Holdings, LLC | $24.19 | 2019 | |
| Philips North America LLC | $20.01 | 2024 | (8021) Zoom In-Office Kits |
| Colgate Oral Pharmaceuticals, INC. | $15.44 | 2020 | |
| Ultradent Products INC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherwin Benlevi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.